iSR'obot MRI-US Fusion

A Robotic Surgery Devices Related Image

(Not Necessarily related to the device)

Description:

iSR'obot MRI-US Fusion by BIOBOT SURGICAL PTE LTD

The iSR'obot MRI-US Fusion by BIOBOT SURGICAL PTE LTD is a revolutionary diagnostic and therapeutic medical device designed to enhance the accuracy of prostate biopsies. This advanced robotic system provides a seamlessly integrated workflow solution for the management of prostate disease.

Employing sophisticated MRI-ultrasound fusion technology, it offers increased accuracy by providing detailed 3D modeling of the prostate and thereby assisting in the precise location of lesions. This fusion technology allows doctors to merge pre-biopsy MR images with ultrasound-guided biopsy images in real time, enhancing the visibility of suspicious areas and improving the targeting accuracy.

The device is highly user-friendly and provides a comfortable experience for the patient. Key features of the system include an intuitive, interactive software interface designed for seamless workflow and ease of use. It also permits systematic and targeted biopsy procedures simultaneously.

With iSR'obot MRI-US Fusion, clinicians can make more informed decisions about managing patients with suspicious prostate conditions. The system reduces the number of unnecessary repeat biopsies, thereby enhancing patient safety, comfort and satisfaction.

Primary Use:

Primary Medical Use of iSR'obot MRI-US Fusion

iSR'obot MRI-US Fusion is a revolutionary addition to the expansive field of surgical robotics. This state-of-the-art device pioneers the fusion of Magnetic Resonance Imaging (MRI) and Ultrasound (US), offering a valuable tool to healthcare professionals in a particularly sensitive niche: prostate biopsies.

Enhanced Precision in Prostate Biopsies

The key task of the iSR'obot MRI-US Fusion is enhancing the accuracy of prostate biopsies. With the dynamic combination of MRI imaging's unrivaled high-resolution soft tissue visibility and ultrasound's real-time imaging capabilities, the device allows for precise targeting of suspect regions during biopsy procedures. In essence, it allows for accurate mapping and targeting of prostate tissue, thereby enhancing diagnostic efficiency and assisting in the formulation of optimized treatment plans.

Improving Patient Outcomes

The iSR'obot MRI-US Fusion contributes significantly towards the advancement of patient care; it reduces the risks associated with invasive surgical procedures and improves the accuracy of prostate cancer diagnosis. The device's imaging technology aids in ensuring that the most clinically significant prostate cancers are efficiently and safely sampled and diagnosed, thereby enhancing the prospects for successful treatment courses. It exemplifies the continuing evolution of technology in medicine and its potential to dramatically improve healthcare outcomes.

In conclusion, the iSR'obot MRI-US Fusion is a significant advancement in the field of surgical robotics, with its primary application in enabling higher precision and safety during prostate biopsies, thereby elevating the standards of care in diagnosing and treating prostate cancer.

How It Works:

Understanding the iSR'obot MRI-US Fusion

The iSR'obot MRI-US Fusion is one of the leading precise surgical instruments currently revolutionizing the field of medicine. Developed to deliver superior accuracy and precision, this instrument integrates conventional trans-rectal ultrasound (TRUS) images with magnetic resonance imaging (MRI). The goal is achieving an optimal biopsy by focusing on specific regions previously marked as suspicious in an MRI.

How does the iSR'obot MRI-US Fusion Work?

The mechanism of this surgical robot is a synthesis of advanced imaging techniques and robotics designed to provide a fusion-guided biopsy. Here's the breakdown of its working principle:
Image Acquisition: Initially, pre-biopsy MRI images of the prostate are obtained. These high-resolution images help enlist regions with possible malignant cell presence. You can refer to an explanation on Magnetic Resonance Imaging. The images are stored for later use.
Image Segmentation: Subsequently, the clinician defines the prostate boundaries on the acquired MRI images. Any suspicious lesions are also marked. This helps later during biopsy, assisting in pinned targeting of defined zones.
Fusion Algorithm: The pre-biopsy MRI images are then co-registered with live TRUS images. The surgical robot uses sophisticated fusion algorithms to merge these images into a 3D model. This model provides better visualization and precision during the biopsy procedure.
Robot-Aided and Trajectory Planning: The clinician uses the iSR'obot MRI-US Fusion to plan the precise path of biopsy needles into the suspicious lesions. The robot also maintains the TRUS probe's stability, offering a consistent, stationary ultrasonographicimage of the prostate.
Biopsy: Finally, using the real-time fusion images as a guide, the needles are administered with precision by the robotic device into the suspected lesion zones. This ensures a targeted biopsy procedure.
Through its outstanding technology and application, the iSR'obot MRI-US Fusion equips clinicians with another layer of accuracy, elevating the dynamic landscape of medical instruments. These advancements entail better patient outcomes, a reduction in the number of unnecessary biopsies, and an overall improvement in diagnostics of diseases such as prostate cancer.